Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,395,291
+$5,847,252 QoQ
Shares Held
108,867
+9.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#513
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $386,755,559 across 13 Drug Manufacturers - General names. ABBV ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
528,937 | $67,968,404 | |
| 2 | BIIB |
Biogen Inc.
|
279,900 | $60,475,194 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
892,969 | $51,452,873 | |
| 4 | JNJ |
Johnson & Johnson
|
200,512 | $50,924,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
381,851 | $48,243,055 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
108,867 | $27,395,291 | |
| 7 | LLY |
ELI LILLY & Co
|
21,971 | $26,352,678 | |
| 8 | PFE |
Pfizer Inc
|
916,205 | $22,062,216 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,395,291 | 108,867 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,548,039 | 99,076 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,653,338 | 86,014 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,222,975 | 48,471 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,825,804 | 36,773 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,807,723 | 32,492 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,044,369 | 28,387 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,023,256 | 45,692 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,903,984 | 46,082 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,214,264 | 61,583 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,883,302 | 44,417 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,968,580 | 73,585 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,381,183 | 54,785 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,189,199 | 26,286 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,170,227 | 31,992 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,237,408 | 53,926 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,000,772 | 52,238 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,721,299 | 47,630 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,662,556 | 56,592 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,358,063 | 105,294 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,502,369 | 57,727 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,349,653 | 67,914 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,419,142 | 59,908 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,042,351 | 34,734 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $19,603,109 | 199,665 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,075,365 | 132,240 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||